Search results
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 5 days agoThe Law Offices of Frank R. Cruz reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Ventyx ...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 7 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 22 hours agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 3 days agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
Brokerages Set Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Target Price at $26.56
ETF DAILY NEWS· 2 days agoArcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the company ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number of other analysts ...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 3 days agoAbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports. Barclays‘s ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie traded as low as $158.56 and last ...
Is Algae Oil the New Fish Oil?
Men's Health via Yahoo News· 4 days agoAlgae oil is all the rage right now as a vegetarian replace to fish oil. Dietitians explain its health benefits, uses, and risks associated with using...